共 50 条
Antiphospholipid Syndrome
被引:56
|作者:
George, Diane
[1
]
Erkan, Doruk
[2
]
机构:
[1] Yale Univ, Dept Rheumatol, Sch Med, New Haven, CT 06520 USA
[2] Cornell Univ, Weill Med Coll, Hosp Special Surg, Barbara Volcker Ctr Women & Rheumat Dis, New York, NY 10021 USA
关键词:
Antiphospholipid syndrome;
Anticardiolipin antibodies;
Lupus anticoagulant;
Myocardial infarction;
SYSTEMIC-LUPUS-ERYTHEMATOSUS;
INTERNATIONAL CONSENSUS STATEMENT;
PRIMARY THROMBOSIS PREVENTION;
ACUTE MYOCARDIAL-INFARCTION;
LIBMAN-SACKS ENDOCARDITIS;
CORONARY-ARTERY-DISEASE;
ANTIBODY-SYNDROME;
RISK-FACTORS;
ANTICARDIOLIPIN ANTIBODIES;
CLASSIFICATION CRITERIA;
D O I:
10.1016/j.pcad.2009.06.005
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
The antiphospholipid syndrome (APS) is an autoimmune systemic disease that is diagnosed when there is vascular thrombosis and/or pregnancy morbidity occurring with persistently positive antiphospholipid antibodies (aPL) (lupus anticoagulant test, anticardiolipin antibodies, and/or anti-β2-glycoprotein I antibodies). Although International APS Classification Criteria have been formulated to provide a uniform approach to APS research, aPL may cause a spectrum of clinical manifestations, some of which are not included in these criteria. The main aPL-related cardiac manifestations include valve abnormalities (vegetations and/or thickening), myocardial infarction (MI), intracardiac thrombi, and myocardial microthrombosis. In this article, we will review the definition, etiopathogenesis, clinical manifestations, diagnosis, and treatment of aPL-related clinical events with emphasis on cardiac manifestations. © 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 125
页数:11
相关论文